QIAGEN N.V. QGEN announced that it partnered with Tecan Group AG. to enhance the processing of QIAGEN's QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test. Notably, Tecan has a strong grip on ...
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
HILDEN, Germany & GERMANTOWN, Md. & SHANGHAI--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QuantiFERON tuberculosis (TB) testing solution has ...
QIAGEN N.V.QGEN recently announced the receipt of Health Canada's approval for QuantiFERON-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect latent tuberculosis (TB) infection. Built on the ...
Germantown, Md. & HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the U.S. launch of an automated ...
Data on performance of QuantiFERON-TB Gold In-Tube test (QFT) and tuberculin skin test (TST) in children with active tuberculosis from high burden countries in the context of micronutrient deficiency ...
Federal health officials are recommending a new, more accurate blood test for tuberculosis that may someday replace the skin test used for the past 100 years. The Centers for Disease Control and ...
Dutch firm wants to incorporate QuantiFERON technology into QIAsymphony and QIAensemble platforms. The board of Australian diagnostics firm Cellestis is backing a proposed $355 million, A$3.55 (about ...
Please provide your email address to receive an email when new articles are posted on . Latent tuberculosis infection screening in patients with hidradenitis suppurativa who are treated with TNF alpha ...
Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback